Quest Diagnostics Reports First Quarter 2022 Financial Results; Raises Guidance for Full Year 2022
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
CFRA Downgrades Quest Diagnostics (DGX) to Hold
April 21, 2022 1:53 PM EDTCFRA downgraded Quest Diagnostics (NYSE: DGX) from Buy to Hold with a price target of $157.00 (from $160.00).
For an analyst ratings summary and ratings history on Quest Diagnostics click here. For more ratings news on Quest Diagnostics click here.
Shares of Quest Diagnostics closed at $138.45 yesterday.
... MoreQuest Diagnostics (DGX) Tops Q1 EPS by 25c, Raises FY EPS Guidance
April 21, 2022 6:46 AM EDTQuest Diagnostics (NYSE: DGX) reported Q1 EPS of $3.22, $0.25 better than the analyst estimate of $2.97. Revenue for the quarter came in at $2.61 billion versus the consensus estimate of $2.63 billion.
GUIDANCE:
Quest Diagnostics sees FY2022 EPS of $9.00-$9.50, versus the consensus of... More
